From 39 reported cases of the "neuroleptic malignant syndrome," three groups were identified: those with concurrent medical problems that could cause fever that accompanied the extrapyramidal symptoms; those with medical problems less clearly related to fever; and those without other medical disorders. Dehydration, infection, pulmonary embolus, and rhabdomyolysis were the common complications o...

objective(s): targeting the neuropeptide systems has been shown to be useful for the development of more effective antipsychotic drugs. neurotensin, an endogenous neuropeptide, appears to be involved in the mechanism of action of antipsychotics. however, the available data provide conflicting results and the mechanism(s) by which antipsychotics affect brain neurotensin neurotransmission have no...

We report a case involving an 81-tear-old man with schizoaffective disorder who presented with neuroleptic malignant syndrome (NMS) after an increase in his neuroleptic dose. NMS, a rare but potentially fatal complication of neuroleptic medications (e.g., antipsychotics, sedatives and antinauseants), is characterized by hyperthermia, muscle rigidity, an elevated creatine kinase level and autono...

The treatment of animals with neuroleptic drugs for periods of a few results in the induction of dopamine (DA) receptor supersensitivity that is reflected, on drugwithdrawal, by enhanced behavioural responses to DA agonist drugs (Muller and Seeman, 1978). Such phenomena have been considered to exemplify the pathophysiology of tardive dyskinesia (Baldessarini and Tarsy, 1980) despite the require...

Chronic treatment of rats with the neuroleptic drugs haloperidol, fluphenazine, and reserpine elicits a 20 to 25% increase in striatal dopamine receptor binding assayed with [3H]haloperidol. This increase in receptor sites may account for behavioral supersensitivity to dopamine receptor stimulants in such animals and for tardive dyskinesia in patients treated with these drugs.

Acute catatonic syndrome is a condition that can be caused by a variety of metabolic, neurological, psychiatric, and toxic conditions, including neuroleptic malignant syndrome. Although ictal catatonia as a manifestation of non-convulsive status epilepticus has been described, reference to the occurrence of seizures in patients with acute catatonic syndrome is anecdotal. Twenty nine patients wi...

Abstract Background Neuroleptic malignant syndrome (NMS) is an uncommon and lethal side effect of neuroleptics. The clinical expression this diverse. Even with criteria diagnosis, it hard to recognize easily. We report a series 25 cases NMS among patients hospitalized in psychiatric service at Oujda for 5 years. have described the characteristics these patients, treatments received, management,...

BACKGROUND Serotonin syndrome is a toxic state, caused by serotonin (5HT) excess in the central nervous system. Serotonin syndrome's main feature is neuro-muscular hyperexcitability, which in many cases is mild but in some cases can become life-threatening. The diagnosis of serotonin syndrome remains challenging since it can only be made on clinical grounds. Three diagnostic criteria systems, S...